REGN
Regeneron Pharmaceuticals
$793.26
−$14.38 (−1.78%)Sep 10, 2026
Key metrics
The numbers that frame REGN today
- Market cap
- $81.67B
- P/E (TTM)
- 18.9
- EV / FCF
- 21.8
- Gross margin
- 84.9%
- EV / Sales
- 5.3
- ROIC
- 15.1%
- Div yield
- 0.46%
- Debt / equity
- 0.1
- 52wk Low
- $538.30
- 52wk High
- $859.34
Growth
Revenue and earnings trend for REGN
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about REGN
Is Regeneron Pharmaceuticals a good buy?
Yes. Regeneron Pharmaceuticals has excellent quality and excellent momentum. Both signals support the setup. Growth looks mixed. The support signal is useful, but not decisive. We think Regeneron Pharmaceuticals is selling at a low price.
What is the market capitalization of REGN?
Regeneron Pharmaceuticals's market capitalization is $81.67B.
What is the P/E ratio for REGN stock?
Regeneron Pharmaceuticals's current P/E ratio is 18.9.
What is the 52-week high for REGN stock?
The 52-week high for Regeneron Pharmaceuticals is $859.34. The current close of $793.26 is 7.7% below that high.
What is the 52-week low for REGN stock?
The 52-week low for Regeneron Pharmaceuticals is $538.30. The current close of $793.26 is 47.4% above that low.
Does REGN stock pay dividends?
Regeneron Pharmaceuticals pays a dividend. The latest dividend per share in the company data is $3.64, which implies a yield of 0.46% based on the current close.
What is the Debt / Equity ratio for REGN?
Regeneron Pharmaceuticals's Debt / Equity ratio is 0.09.